Posted by & filed under Part 1 Business in a Global Environment, Part 4: Marketing Management, Part 6 Managing Financial Resources.

Description: Pfizer on Tuesday raised the full-year sales forecast for its Covid-19 vaccine by 7.5% to $36 billion, as it signs deals with countries for booster doses and receives clearances for using its shots in children.

Source: – video report

Date: Nov 02, 2021


?Questions for discussion:

  • What can affect Pfizer’s future vaccine revenues?
  • Do you think the stock is a good buy or too great a risk because of these factors?

Leave a Reply